Sfoglia per Autore
Efficacy and toxicity of weekly Docetaxel as second/third line chemotherapy for advanced Non Small Cell lung cancer (NSCLC)
2005-01-01 Marabello, Grazia; Buemi, B.; Gnani, Alessandro; Santarpia, Mariacarmela; Galletti, G.; Saetta, C.; Iacono, C.; Altavilla, Giuseppe
Applications of genomics in NSCLC
2005-01-01 ROSELL R; COBO M; ISLA D; SANCHEZ JM; TARON M; ALTAVILLA G.; SANTARPIA M; MORAN T; CATOT S; ETXANIZ O.
From the bench to the bed: individualizing treatment in non-small-cell lungcancer
2006-01-01 Santarpia, Mariacarmela; Altavilla, Giuseppe; Salazar, F; Tarón, M; Rosell, R.
Usefulness of predictive tests for cancer treatment
2006-01-01 Rosell, R; Cuello, M; Cecere, F; Santarpia, Mariacarmela; Reguart, N; Felip, E; Taron, M.
PIK3CA mutations in breast cancer: a potential marker
2006-01-01 Santarpia, Mariacarmela; Altavilla, Giuseppe; Margeli, M; Mesiti, M; Cavallari, Vittorio; Ciraqui, B; Reguart, N; Barbadas, A; Taron, M; Rosell, R.
Treatment of non-small-cell lung cancer and pharmacogenomics: where we are andwhere we are going
2006-01-01 ROSELL R; CUELLO M; CECERE F; SANTARPIA M.; REGUART N; FELIP E; TARON M
PIK3CA mutations in breast cancer: A potential predictive marker
2006-01-01 Santarpia, Mariacarmela; Rosell, R; Margeli, M; Mesiti, M; Cavallari, Vittorio; Pitini, Vincenzo; Cirauqui, B; Reguart, N; Barnadas, A; Taron, M; Altavilla, Giuseppe
PIK3CA mutations: a potential predictive marker in advanced breast cancer treated with antimicrotubule-based chemotherapy.
2006-01-01 Cirauqui, Beatriz; Ramírez, Jose Luis; Santarpia, Mariacarmela; Tarón, Miquel; Castellà, Eva; Sánchez Ronco, María; Layos, Laura; Margelí, Mireia; Rosell, Rafael .
Predicting the outcome of chemotherapy for lung cancer.
2006-01-01 ROSELL R; CECERE F; SANTARPIA M.; REGUART N; TARON M
Polymorphisms in DNA repair genes modulate survival incisplatin/gemcitabine-treated non-small-cell lung cancer patients
2006-01-01 DE LAS PEÑAS, R; SANCHEZ RONCO, M; Alberola, V; Taron, M; Camps, C; GARCIA CARBONERO, R; Massuti, B; Queralt, C; Botia, M; GARCIA GOMEZ, R; Isla, D; Cobo, M; Santarpia, Mariacarmela; Cecere, F; Mendez, P; Sanchez, Jj; Rosell, R.
Retrospective analiysis of P-STAT6 expression as predictive marker in primary nervous system lymphoma patients assigned to high-dose methotrexate
2007-01-01 Altavilla, Giuseppe; Pitini, V; Arrigo, C; Marabello, G; Naro, C; Tomasello, Chiara; Santarpia, Mariacarmela
Implications of XPD312 in stage IIIA-B NSCLC
2007-01-01 Santarpia, Mariacarmela
Methylation of Mad2 in serum DNA of docetaxel/cisplatin-treated stage IV non-small-cell lung cancer.
2007-01-01 Santarpia, Mariacarmela; Salazar, M. F.; Ramirez, J. L.; Molina, M. A.; Altavilla, Giuseppe; Taron, M.
Mosaicism in von Hippel-Lindau disease: an event important to recognize
2007-01-01 Santarpia, L; Sarlis, Nj; Santarpia, Mariacarmela; Sherman, Si; Trimarchi, Francesco; Benvenga, Salvatore
Association between XPD 312 single nucleotide polymorphism (SNP) and clinical outcome in stage IIIA-B non-small-cell lung cancer (NSCLC) patients (P) < 59 years (Y) treated with chemotherapy followed by surgery
2007-01-01 Santarpia, Mariacarmela; Garrido, Pilar; Taron, Miquel; Sanchez Ronco, Maria; Pitini, Vincenzo; Rosell, Rafael; Altavilla, Giuseppe
Retrospective analysis of P-STAT6 expression as a predictive marker in primary nervous system lymphoma patients assigned to high-dose methotrexate
2007-01-01 Altavilla, Giuseppe; Pitini, Vincenzo; Arrigo, Carmela; Marabello, Grazia; Naro, Claudia; Tomasello, Chiara; Santarpia, Mariacarmela
Age-related genetic abnormalities: the Achilles’ heel for customizing therapy in elderly lung cancer patients
2007-01-01 Rosell, R; Santarpia, Mariacarmela; Moran, T; Salazar M., F; Kaen D., L; Ramirez, J. L.
Emerging drugs for non-small-cell lung cancer.
2007-01-01 Felip, E; Santarpia, Mariacarmela; Rosell, R.
Subcutaneous low-dose alemtuzumab as first line therapy for elderly CLL patients with deletion of 17p
2008-01-01 V., Pitini; C., Arrigo; C., Naro; B., Buemi; G., Marabello; Santarpia, Mariacarmela; Altavilla, Giuseppe
BRCA1 and anti-angiogenesis: new perspectives on the treatment of non-small-cell lung cancer
2008-01-01 Santarpia, Mariacarmela; Altavilla, Giuseppe; Taron, M.; Rosell, R.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Efficacy and toxicity of weekly Docetaxel as second/third line chemotherapy for advanced Non Small Cell lung cancer (NSCLC) | 1-gen-2005 | Marabello, Grazia; Buemi, B.; Gnani, Alessandro; Santarpia, Mariacarmela; Galletti, G.; Saetta, C.; Iacono, C.; Altavilla, Giuseppe | |
Applications of genomics in NSCLC | 1-gen-2005 | ROSELL R; COBO M; ISLA D; SANCHEZ JM; TARON M; ALTAVILLA G.; SANTARPIA M; MORAN T; CATOT S; ETXANIZ O. | |
From the bench to the bed: individualizing treatment in non-small-cell lungcancer | 1-gen-2006 | Santarpia, Mariacarmela; Altavilla, Giuseppe; Salazar, F; Tarón, M; Rosell, R. | |
Usefulness of predictive tests for cancer treatment | 1-gen-2006 | Rosell, R; Cuello, M; Cecere, F; Santarpia, Mariacarmela; Reguart, N; Felip, E; Taron, M. | |
PIK3CA mutations in breast cancer: a potential marker | 1-gen-2006 | Santarpia, Mariacarmela; Altavilla, Giuseppe; Margeli, M; Mesiti, M; Cavallari, Vittorio; Ciraqui, B; Reguart, N; Barbadas, A; Taron, M; Rosell, R. | |
Treatment of non-small-cell lung cancer and pharmacogenomics: where we are andwhere we are going | 1-gen-2006 | ROSELL R; CUELLO M; CECERE F; SANTARPIA M.; REGUART N; FELIP E; TARON M | |
PIK3CA mutations in breast cancer: A potential predictive marker | 1-gen-2006 | Santarpia, Mariacarmela; Rosell, R; Margeli, M; Mesiti, M; Cavallari, Vittorio; Pitini, Vincenzo; Cirauqui, B; Reguart, N; Barnadas, A; Taron, M; Altavilla, Giuseppe | |
PIK3CA mutations: a potential predictive marker in advanced breast cancer treated with antimicrotubule-based chemotherapy. | 1-gen-2006 | Cirauqui, Beatriz; Ramírez, Jose Luis; Santarpia, Mariacarmela; Tarón, Miquel; Castellà, Eva; Sánchez Ronco, María; Layos, Laura; Margelí, Mireia; Rosell, Rafael . | |
Predicting the outcome of chemotherapy for lung cancer. | 1-gen-2006 | ROSELL R; CECERE F; SANTARPIA M.; REGUART N; TARON M | |
Polymorphisms in DNA repair genes modulate survival incisplatin/gemcitabine-treated non-small-cell lung cancer patients | 1-gen-2006 | DE LAS PEÑAS, R; SANCHEZ RONCO, M; Alberola, V; Taron, M; Camps, C; GARCIA CARBONERO, R; Massuti, B; Queralt, C; Botia, M; GARCIA GOMEZ, R; Isla, D; Cobo, M; Santarpia, Mariacarmela; Cecere, F; Mendez, P; Sanchez, Jj; Rosell, R. | |
Retrospective analiysis of P-STAT6 expression as predictive marker in primary nervous system lymphoma patients assigned to high-dose methotrexate | 1-gen-2007 | Altavilla, Giuseppe; Pitini, V; Arrigo, C; Marabello, G; Naro, C; Tomasello, Chiara; Santarpia, Mariacarmela | |
Implications of XPD312 in stage IIIA-B NSCLC | 1-gen-2007 | Santarpia, Mariacarmela | |
Methylation of Mad2 in serum DNA of docetaxel/cisplatin-treated stage IV non-small-cell lung cancer. | 1-gen-2007 | Santarpia, Mariacarmela; Salazar, M. F.; Ramirez, J. L.; Molina, M. A.; Altavilla, Giuseppe; Taron, M. | |
Mosaicism in von Hippel-Lindau disease: an event important to recognize | 1-gen-2007 | Santarpia, L; Sarlis, Nj; Santarpia, Mariacarmela; Sherman, Si; Trimarchi, Francesco; Benvenga, Salvatore | |
Association between XPD 312 single nucleotide polymorphism (SNP) and clinical outcome in stage IIIA-B non-small-cell lung cancer (NSCLC) patients (P) < 59 years (Y) treated with chemotherapy followed by surgery | 1-gen-2007 | Santarpia, Mariacarmela; Garrido, Pilar; Taron, Miquel; Sanchez Ronco, Maria; Pitini, Vincenzo; Rosell, Rafael; Altavilla, Giuseppe | |
Retrospective analysis of P-STAT6 expression as a predictive marker in primary nervous system lymphoma patients assigned to high-dose methotrexate | 1-gen-2007 | Altavilla, Giuseppe; Pitini, Vincenzo; Arrigo, Carmela; Marabello, Grazia; Naro, Claudia; Tomasello, Chiara; Santarpia, Mariacarmela | |
Age-related genetic abnormalities: the Achilles’ heel for customizing therapy in elderly lung cancer patients | 1-gen-2007 | Rosell, R; Santarpia, Mariacarmela; Moran, T; Salazar M., F; Kaen D., L; Ramirez, J. L. | |
Emerging drugs for non-small-cell lung cancer. | 1-gen-2007 | Felip, E; Santarpia, Mariacarmela; Rosell, R. | |
Subcutaneous low-dose alemtuzumab as first line therapy for elderly CLL patients with deletion of 17p | 1-gen-2008 | V., Pitini; C., Arrigo; C., Naro; B., Buemi; G., Marabello; Santarpia, Mariacarmela; Altavilla, Giuseppe | |
BRCA1 and anti-angiogenesis: new perspectives on the treatment of non-small-cell lung cancer | 1-gen-2008 | Santarpia, Mariacarmela; Altavilla, Giuseppe; Taron, M.; Rosell, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile